Author： Mandell L.A.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.59, Iss.5, 2000-05, pp. : 1148-1148
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :
Access to resources
Recommend
Gemifloxacin: a new fluoroquinolone
By Blondeau Joseph M Missaghi Bayan
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. :
Gemifloxacin offers advantages over clarithromycin for AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Gemifloxacin: Factive, LB 20304, SB 265805
Drugs in R&D, Vol. 3, Iss. 4, 2002-01 ,pp. :
Gemifloxacin offers advantages over clarithromycin for AECB
Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. :